C O M M U N I C A T I O N S
Table 2. Reaction with Various Dienesa
complete ref 4h. This material is available free of charge via the Internet
References
(1) For a general review of hetero-Diels-Alder reactions, see: (a) The Diels-
Alder Reaction: Selected Practical Methods; Fringuelli, F., Taticchi, A.,
Eds.; John Wiley & Sons: New York, 2002. (b) Cycloaddition Reactions
in Organic Synthesis; Kobayashi, S., Jørgensen, K. A., Eds.; Wiley-VCH:
Weinheim, Germany, 2002; pp 151-209. (c) ComprehensiVe Asymmetric
Catalysis III; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer:
Berlin, 1999; pp 1237-1254. (d) Gouverneur, V.; Reiter, M. Chem.s
Eur. J. 2005, 11, 5806. (e) Jørgensen, K. A. Angew. Chem., Int. Ed. 2000,
39, 3558. (f) Tietze, L. F.; Kettschau, G. Top. Curr. Chem. 1997, 189, 1.
(2) (a) Yamamoto, Y.; Yamamoto, H. Eur. J. Org. Chem. 2006, 2031. (b)
Yamamoto, Y.; Yamamoto, H. Angew. Chem., Int. Ed. 2005, 44, 7082;
Angew. Chem. 2005, 117, 7244. (c) Yamamoto, Y.; Yamamoto, H. J.
Am. Chem. Soc. 2004, 126, 4128.
(3) (a) Chowdari, N. S.; Ahmad, M.; Albertshofer, K.; Tanaka, F.; Barbas,
C. F., III. Org. Lett. 2006, 8, 2839. (b) Reetz, M. T. Chem. ReV. 1999,
99, 1121. (c) Patel, M.; Kaltenbach, R. F., III; Nugiel, D. A.; McHugh,
R. J., Jr.; Jadhav, P. K.; Bacheler, L. T.; Cordova, B. C.; Klabe, R. M.;
Erickson, V. S.; Garber, S.; Reid, C.; Seitz, S. P. Bioorg. Med. Chem.
Lett. 1998, 8, 1077. (d) Reedijk, J. Chem. Commun. 1996, 801. (e) Konradi,
A. W.; Pedersen, S. F. J. Org. Chem. 1992, 57, 28. (f) Cummins, C. C.;
Beachy, M. D.; Schrock, R. R.; Vale, M. G.; Sankaran, V.; Cohen, R. E.
Chem. Mater. 1991, 3, 1153.
(4) (a) Izawa, K.; Onishi, T. Chem. ReV. 2006, 106, 2811. (b) Specker, E.;
Bo¨ttcher, J.; Brass, S.; Heine, A.; Lilie, H.; Schoop, A.; Mu¨ller, G.;
Griebenow, N.; Klebe, G. Chem. Med. Chem. 2006, 1, 106. (c) Engstrom,
K.; Henry, R.; Hollis, L. S.; Kotecki, B.; Marsden, I.; Pu, Y.-M.; Wagaw,
S.; Wang, W. J. Org. Chem. 2006, 71, 5369. (d) Yeung, C. M.; Klein, L.
L.; Flentge, C. A.; Randolph, J. T.; Zhao, C.; Sun, M.; Dekhtyar, T.; Stoll,
V. S.; Kempf, D. J. Bioorg. Med. Chem. Lett. 2005, 15, 2275. (e) Ikunaka,
M. Chem.sEur. J. 2003, 9, 378. (f) Abdel-Rahman, H. M.; Al-Karamany,
G. S.; El-Koussi, N. A.; Youssef, A. F.; Kiso, Y. Curr. Med. Chem. 2002,
9, 1905. (g) Ghosh, A. K.; Bilcer, G.; Schiltz, G. Synthesis 2001, 2203.
(h) Kempf, D. J.; et al. J. Med. Chem. 1998, 41, 602. (i) Ettmayer, P.;
Hu¨bner, M.; Gstach, H. Tetrahedron Lett. 1994, 35, 3901. (j) Kempf, D.
J.; Codacovi, L.; Wang, X. C.; Kohlbrenner, W. E.; Wideburg, N. E.;
Saldivar, A.; Vasavanonda, S.; Marsh, K. C.; Bryant, P.; Sham, H. L.;
Green, B. E.; Betebenner, D. A.; Erickson, J.; Norbeck, D. W. J. Med.
Chem. 1993, 36, 320.
(5) (a) Robiette, R.; Cheboub-Benchaba, K.; Peeters, D.; Marchand, B. J. J.
Org. Chem. 2003, 68, 9809. (b) Adam, W.; Bosio, S. G.; Degen, H.-G.;
Krebs, O.; Stalke, D.; Schumacher, D. Eur. J. Org. Chem. 2002, 3944.
(c) Urabe, H.; Kusaka, K.; Suzuki, D.; Sato, F. Tetrahedron Lett. 2002,
43, 285. (d) Zhang, A.; Kan, Y.; Jiang, B. Tetrahedron 2001, 57, 2305.
(e) Kaname, M.; Arakawa, Y.; Yoshifuji, S. Tetrahedron Lett. 2001, 42,
2713. (f) Dussault, P. H.; Han, Q.; Sloss, D. G.; Symonsbergen, D. J.
Tetrahedron 1999, 55, 11437. (g) Wyatt, P. B.; Villalonga-Barber, C.;
Motevalli, M. Tetrahedron Lett. 1999, 40, 149. (h) Aspinall, I. H.; Cowley,
P. M.; Mitchell, G.; Raynor, C. M.; Stoodley, R. J. J. Chem. Soc., Perkin
Trans. 1 1999, 2591. (i) Virgili, M.; Moyano, A.; Pericas, M. A.; Riera,
A. Tetrahedron 1999, 55, 3959. (j) Aspinall, I. H.; Cowley, P. M.; Mitchell,
G.; Stoodley, R. J. J. Chem. Soc., Chem. Commun. 1993, 1179.
(6) Aburel, P. S.; Zhuang, W.; Hazell, R. G.; Jørgensen, K. A. Org. Biomol.
Chem. 2005, 3, 2344.
yield
(%)
ee
entry
diene
R1
R2
(%)b
1
2
3
4
5
6
7
8
9
2a
Me
Me
n-C5H11
i-Pr
87 >99
84
65
2b Me
2c Me
2d Me
2e
2f
95
84
98
92
90
95
98
98
92
55
CH2CH2CH2CO2Me 74
Bn
Me
Me
i-Bu
CH2OBn
74
85
82
84
77
78
70
4-MOMO-Bn
CH2CH2CH2OTBS
2g
2h CH2CH2CH2OTBS
2i
2j
CH2CH2CH2NNsBoc i-Bu
10
Me
2-Furyl
Ph
11c
2k Me
a Reaction was conducted with AgOTf (10 mol %), (R)-BINAP (5 mol
%), azopyridine (1 equiv), and silyloxydiene (2 equiv) under Ar at -78 °C
and gradually warmed to -40 °C over 3 h. b Enantiomeric excess value
was determined by HPLC (Supporting Information). c 20 mol % of AgOTf
and 10 mol % of (R)-BINAP were used.
Scheme 2. Conversion to Protected Diamino Alcohola
a Conditions: (a) (i) TBAF, AcOH, (ii) NaBH4, (iii) TlPSOTf, NEt3,
65% (3 steps); (b) (i) MeOTf, (ii) NaOH, (iii) TFAA, NEt3, 71% (3 steps);
(c) SmI2, MeOH, 71%.
Scheme 3. Determination of Absolute Stereochemistrya
a Conditions: (a) (i) Zn, AcOH, (ii) TBAF, AcOH, (iii) NaBH4, 53%
(3 steps).
(7) For synthesis of similar compounds, see: Srinivasan, V.; Jebaratnam, D.
J.; Budil, D. E. J. Org. Chem. 1999, 64, 5644.
(8) The reaction of 2-triisopropylsilyloxy-1,3-cyclohexadiene with CuPF6(CH3-
CN)4 and (R)-BINAP gave the corresponding adduct with >99% ee. The
origin of this result is being investigated in our laboratory.
(9) Reactions using the following metal catalysts were checked on TLC: Al,
B, Mg, Zn, Ti, Sc, Hf, Yb, Zr, In, La. None of them accelerated the
reaction.
(10) Momiyama, N.; Yamamoto, H. J. Am. Chem. Soc. 2004, 126, 5360.
(11) For synthesis of silyloxydienes, see: (a) Nakashima, D.; Yamamoto, H.
J. Am. Chem. Soc. 2006, 128, 9626. (b) Yamamoto, Y.; Yamamoto, H.
Angew. Chem., Int. Ed. 2005, 44, 7082.
(12) Excess amount of AcOH was necessary to avoid epimerization of the
methyl group via retro-Michael reaction.
(13) For SmI2-mediated cleavage of the N-N bond with trifluoroacetyl group,
see: (a) Chowdari, N. S.; Barbas, C. F., III. Org. Lett. 2005, 7, 867. (b)
Ding, H.; Friestad, G. K. Org. Lett. 2004, 6, 637.
ridine (1) and silver(I)-BINAP 2:1 catalyst. This catalytic process
could be one of the effective synthetic routes to a number of chiral
1,4-diamines which are pharmaceutically important compounds.
Further studies of the detailed mechanism of the reaction and
synthetic applications are currently underway in our laboratory.
Acknowledgment. Support of this research was provided by
National Institutes of Health (NIH) Grant No. GM068433-01, and
Merck Research Laboratories. We thank Dr. Ian M. Steel for X-ray
crystallographic analysis.
Supporting Information Available: Experimental details, spec-
troscopic data, including determination of absolute configuration, and
JA066726Y
9
J. AM. CHEM. SOC. VOL. 128, NO. 51, 2006 16483